chr6-104796988-G-A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_020771.4(HACE1):c.655C>T(p.Arg219Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000562 in 1,600,278 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_020771.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HACE1 | NM_020771.4 | c.655C>T | p.Arg219Ter | stop_gained | 8/24 | ENST00000262903.9 | NP_065822.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HACE1 | ENST00000262903.9 | c.655C>T | p.Arg219Ter | stop_gained | 8/24 | 1 | NM_020771.4 | ENSP00000262903 | P1 | |
HACE1 | ENST00000416605.6 | c.*212C>T | 3_prime_UTR_variant, NMD_transcript_variant | 9/26 | 1 | ENSP00000392425 | ||||
HACE1 | ENST00000369125.6 | c.655C>T | p.Arg219Ter | stop_gained | 8/19 | 2 | ENSP00000358121 | |||
HACE1 | ENST00000519645.5 | c.523C>T | p.Arg175Ter | stop_gained | 7/8 | 5 | ENSP00000429765 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152110Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000552 AC: 8AN: 1448168Hom.: 0 Cov.: 27 AF XY: 0.00000416 AC XY: 3AN XY: 721482
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152110Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74300
ClinVar
Submissions by phenotype
Spastic paraplegia-severe developmental delay-epilepsy syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Dec 21, 2020 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 04, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at